Cartesian Therapeutics
NASDAQ: RNAC
$8.03
+0.17
(+2.16%)
as on
Cartesian Therapeutics Stock Performance
as on September 19, 2026 at 2:16 pm IST
Day's Low
Day's High
$7.66$8.26
4.61%
Downside
2.86%
Upside
52 Week's Low
52 Week's High
$5.60$11.0030.26%
Downside
36.99%
Upside
Cartesian Therapeutics share price movements today
- Previous Close
- $7.86
- Open
- $7.82
- Volume
- 475.9K
- Market Cap
- $239.3M
- Day's Low - High
- $7.66 - $8.26
- 52 Week Low - High
- $5.60 - $11.00
Cartesian Therapeutics Historical Returns
- 1 Month Return
- -25.07 %
- 3 Month Return
- -18.38 %
- 1 Year Return
- -16.74 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Cartesian Therapeutics Stock Fundamentals & Key Indicators
Check Cartesian Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$239.3M
EPS (TTM)
-5.93
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.33
Industry PE ratio
-2.37
PEG Ratio
0.00713530417093496
EBITDA
-157.6M
Revenue (TTM)
1.5M
Profit Margin
-766.42%
Return On Equity TTM
141.41%
Cartesian Therapeutics Stock Valuation
Track how Cartesian Therapeutics P/E has moved over time to understand its valuation trends.
Cartesian Therapeutics in the last 5 years
Lowest (-12.09x)
December 31, 2021
Industry (-2.37x)
December 31, 2025
Today (-1.44x)
December 31, 2025
Highest (3.85x)
December 31, 2022
Today’s Price to Earnings Ratio: -1.44x
Cartesian Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Cartesian Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $239.3M | NA | -1.33 | -766.42% | 0.00% | |
| BUY | $63.1B | -63.24% | -19.81 | -12.57% | 0.00% | |
| BUY | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| BUY | $79.7B | 21.1% | 18.48 | 84.86% | 0.48% |
Stock Returns calculator for Cartesian Therapeutics Stock including INR - Dollar returns
The Cartesian Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Cartesian Therapeutics investment value today
Current value as on today
₹92,363
Returns
Returns from Cartesian Therapeutics Stock
Dollar Impact
₹7,299 (+7.3%)
Analyst Recommendation on Cartesian Therapeutics Stock
Based on 6 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Cartesian Therapeutics. Average target price of $34.57
Cartesian Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Cartesian Therapeutics.
What analysts predicted
76.77%UPSIDE
Target Price
$34.57
Current Price
$8.03
Analyzed by
6 Analysts
Target
$34.57
Cartesian Therapeutics target price $34.57, a slight upside of 76.77% compared to current price of $8.03. According to 6 analysts rating.
Indian Investors' Interest in Cartesian Therapeutics Stock
Search interest for Cartesian Therapeutics Stock has increased by 169% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:169% versus previous 30 day period
Cartesian Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Cartesian Therapeutics Annual Profit & Loss
All numbers in Millions USD
Cartesian Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Cartesian Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Cartesian Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -92.57M → 13.72M (in $), with an average increase of 260.9% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, RNAC has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 525.2%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 947.0K → 78.0K (in $), with an average decrease of 91.8% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, RNAC stock has moved down by -21.5%
About Cartesian Therapeutics
| Organisation | Cartesian Therapeutics |
| Headquarters | 7495 New Horizon Way, Frederick, MD, 21703, US |
| Industry | Biotechnology |
| CEO | Carsten Brunn |
| E-voting on shares | Click here to vote |
Key Management of Cartesian Therapeutics
Name | Title |
|---|---|
Ms. June Seymour | Chief Accounting Officer |
Mr. Matthew Bartholomae J.D. | General Counsel & Secretary |
Dr. Peter G. Traber M.D. | Head of R&D |
Dr. Carsten Brunn Ph.D. | President, CEO & Chairman of the Board |
Mr. Blaine T. Davis | Chief Financial Officer |
Dr. Emily English Ph.D. | Chief Operating Officer |
FAQs
What is Cartesian Therapeutics share price today?
Cartesian Therapeutics share price today is $8.03 as on at the close of the market. Cartesian Therapeutics share today touched a day high of $8.26 and a low of $7.66.
What is the 52 week high and 52 week low for Cartesian Therapeutics share?
Cartesian Therapeutics share touched a 52 week high of $11.00 on and a 52 week low of $5.60 on . Cartesian Therapeutics stock price today i.e. is closed at $8.03,which is 27.00% down from its 52 week high and 43.39% up from its 52 week low.
What is Cartesian Therapeutics's market capitalisation today?
Cartesian Therapeutics market capitalisation is $0.00T as on .
How to invest in Cartesian Therapeutics Stock (RNAC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Cartesian Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cartesian Therapeutics Shares that will get you 0.1868 shares as per Cartesian Therapeutics share price of $8.03 per share as on September 19, 2026 at 8:46 am IST.
What is the minimum amount required to buy Cartesian Therapeutics Stock (RNAC) from India?
Indian investors can start investing in Cartesian Therapeutics (RNAC) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Cartesian Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cartesian Therapeutics share’s latest price of $8.03 as on September 19, 2026 at 8:46 am IST, you will get 1.2453 shares of Cartesian Therapeutics. Learn more about
fractional shares .